Book Value per Share: GeneDx Holdings (WGS)

Graphic logo of GeneDx Holdings Corp. (WGS)

The current market quotes on GURU.Markets visualized below demonstrate the price action of GeneDx Holdings Corp. (WGS), whose indicators stand at 8.18. GeneDx Holdings Corp. (WGS) leverages the expertise of bioinformaticians and consultant experts to create a global scientific hub environment. Stable revenue is secured by integrating DNA analysis into medical standards, while operational challenges are mitigated by prioritizing high-margin genomic research, despite potential changes in insurance reimbursements.

GeneDx Holdings (WGS) Equity per Share: for the period 04/28/2023 - 10/28/2026

Summary analytical data breakdowns for genedx.com (WGS)

- price and consensus price forecast:
Price Chart Sema4|WGS - Analyst Median Target
- market capitalization data:
Market Capitalization GeneDx Holdings|WGS - Business Value
- book capitalization data:
Net Assets per Single Share GeneDx|WGS - Accounting Capitalization|Market Capitalization to Book Value Ratio genedx.com|WGS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital GeneDx Holdings Corp.|WGS - Long-Term Indebtedness to Equity|Short-Term Debt to Capital GeneDx|WGS - Company Cumulative Debt|Debt to Book Capitalization Ratio GeneDx Holdings|WGS - Company Long-Term Indebtedness|Company Short-Term Debts GeneDx
Fundamental company valuation:GeneDx Holdings Corp.
Brand item of genedx.com

Book value per share is calculated by dividing the company's total equity by the number of outstanding shares. This metric determines the actual asset backing of the business, excluding market price fluctuations. For GeneDx Holdings Corp. (WGS), investments in robotic AI sequencing complexes directly impact the structure of net assets. The increase in equipment value enhances the issuer's fundamental stability. By analyzing the book value per share chart, an investor assesses the internal capital reserve.

Competitors of GeneDx Holdings Corp. (WGS)

Net Assets per Single Share TEM (Tempus AI, Inc.)|QGEN - Net Assets per Share|Book Value per Share Ionis Pharmaceuticals|RGEN (repligen.com) - Equity per Share|Net Assets per Single Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRISPR Therapeutics Inc|Book Value per Share RARE|Book Value per Share Beam Tx (BEAM)|SRPT (Sarepta Therapeutics, Inc.) - Book Value per Share|Book Value of One Share twistbioscience.com TWST|TXG (10x Genomics) - Book Value per Share|NTLA: Net Asset Value per Share|Net Assets per Single Share Stoke|BioLife (BLFS) - Equity per Share|Book Value per Share WVE (Wave Life Sciences)|Net Asset Value per Share mazetx.com|Book Value per Share Sionna Therapeutics SION|Equity per Share Prime Medicine Inc PRME|TSHA - Accounting Value per Share|QURE - Equity per Share|Accounting Value per Share MeiraGTx Holdings plc (MGTX)|RGNX - Accounting Value of a Share|Book Value per Share Solid Biosciences SLDB|OCGN (Ocugen Inc) - Accounting Value of a Share|Net Assets per Single Share PACB (Pacific Biosciences of California)|Net Asset Value per Share BNTC|Net Assets per Single Share Design Therapeutics (DSGN)|Net Assets per Single Share rocketpharma.com (RCKT)|FDMT - Book Value per Share|Equity per Share Lexeo Therapeutics Inc. LXEO|Book Value per Share KRRO (Korro Bio, Inc)|EDIT: Net Assets per Share|Net Assets per Single Share Silence Therapeutics|ProQR Therapeutics (PRQR) - Equity per Share|Codexis Inc - Book Value per Share|Book Value of One Share SGMO|NAUT (Nautilus Biotechnology) - Net Assets per Single Share|Net Assets per Share Metagenomi Therapeutics MGX|Accounting Value per Share Precision BioSciences, Inc.|Accounting Value of a Share Generation Bio Co GBIO|BOLD: Book Value per Share|XCUR: Accounting Value per Share|Net Assets per Single Share IMNN|PHIO (Phio Pharmaceuticals Corp.) - Net Asset Value per Share|MBIO - Net Assets per Single Share|Accounting Value of a Share RNAZ|BNGO - Net Assets per Single Share|Share Book Value Applied DNA Sciences Inc APDN|Accounting Value per Share BLUE|IPA - Net Assets per Share|OMGA: Accounting Value per Share|OMIC - Accounting Value per Share|Book Value per Share RGLS (Regulus Therapeutics Inc.)|SYRS (Syros Pharmaceuticals Inc.) - Book Value of One Share|TBIO: Net Assets per Single Share|Net Assets per Share TRACON Pharmaceuticals, Inc|Book Value per Share Unity Biotechnology UBX